中华心律失常学杂志
中華心律失常學雜誌
중화심률실상학잡지
CHINESE JOURNAL OF CARDIAC ARRHYTHMIAS
2014年
2期
83-88
,共6页
刘兴鹏%田颖%尹先东%周旭%石亮%王彦江%刘小青%杨新春
劉興鵬%田穎%尹先東%週旭%石亮%王彥江%劉小青%楊新春
류흥붕%전영%윤선동%주욱%석량%왕언강%류소청%양신춘
心血管病学%心房颤动%导管消融%抗心律失常药物
心血管病學%心房顫動%導管消融%抗心律失常藥物
심혈관병학%심방전동%도관소융%항심률실상약물
Cardiology%Atrial fibrillation%Catheter ablation%Anti-arrhythmic drug
目的:报道小剂量伊布利特辅助下进行持续性心房颤动(房颤)导管消融治疗的初步结果。方法前瞻性入选2011年11月至2013年4月连续102例在首都医科大学附属北京朝阳医院心内科接受导管消融治疗的持续性房颤患者,其中男68例,女34例,平均年龄(62±11)岁。首先行环肺静脉电隔离术( CPVI),然后静脉给予0.25 mg的伊布利特,观察30 min。如房颤转复为窦性心律( SR)则不予进一步的心房基质改良;如房颤转为房性心动过速( AT)则仅消融AT;如仍为房颤,则行心房碎裂电位( CFAE )消融,直至 SR 恢复或 CFAE 已被消除或 CFAE 消融时间已达30 min。结果41例(40.2%)患者经CPVI±小剂量伊布利特后房颤被终止(SR或者AT)为组1。其余61例(59.8%)患者进一步接受了平均时间为(14.0±5.6) min 的CFAE消融,其中25例(41.0%)患者房颤被终止为组2;36例患者经电复律恢复SR为组3。平均随访(501±224) d,单次消融成功率为69.6%(71例)。组1和组2的成功率(分别为82.9%和76.0%)显著高于组3(50.0%,P值均<0.01)。结论小剂量伊布利特辅助的持续性房颤导管消融术疗效可以接受,并在实时评估房颤维持基质及减少无效CFAE消融等方面具有潜在优势。
目的:報道小劑量伊佈利特輔助下進行持續性心房顫動(房顫)導管消融治療的初步結果。方法前瞻性入選2011年11月至2013年4月連續102例在首都醫科大學附屬北京朝暘醫院心內科接受導管消融治療的持續性房顫患者,其中男68例,女34例,平均年齡(62±11)歲。首先行環肺靜脈電隔離術( CPVI),然後靜脈給予0.25 mg的伊佈利特,觀察30 min。如房顫轉複為竇性心律( SR)則不予進一步的心房基質改良;如房顫轉為房性心動過速( AT)則僅消融AT;如仍為房顫,則行心房碎裂電位( CFAE )消融,直至 SR 恢複或 CFAE 已被消除或 CFAE 消融時間已達30 min。結果41例(40.2%)患者經CPVI±小劑量伊佈利特後房顫被終止(SR或者AT)為組1。其餘61例(59.8%)患者進一步接受瞭平均時間為(14.0±5.6) min 的CFAE消融,其中25例(41.0%)患者房顫被終止為組2;36例患者經電複律恢複SR為組3。平均隨訪(501±224) d,單次消融成功率為69.6%(71例)。組1和組2的成功率(分彆為82.9%和76.0%)顯著高于組3(50.0%,P值均<0.01)。結論小劑量伊佈利特輔助的持續性房顫導管消融術療效可以接受,併在實時評估房顫維持基質及減少無效CFAE消融等方麵具有潛在優勢。
목적:보도소제량이포리특보조하진행지속성심방전동(방전)도관소융치료적초보결과。방법전첨성입선2011년11월지2013년4월련속102례재수도의과대학부속북경조양의원심내과접수도관소융치료적지속성방전환자,기중남68례,녀34례,평균년령(62±11)세。수선행배폐정맥전격리술( CPVI),연후정맥급여0.25 mg적이포리특,관찰30 min。여방전전복위두성심률( SR)칙불여진일보적심방기질개량;여방전전위방성심동과속( AT)칙부소융AT;여잉위방전,칙행심방쇄렬전위( CFAE )소융,직지 SR 회복혹 CFAE 이피소제혹 CFAE 소융시간이체30 min。결과41례(40.2%)환자경CPVI±소제량이포리특후방전피종지(SR혹자AT)위조1。기여61례(59.8%)환자진일보접수료평균시간위(14.0±5.6) min 적CFAE소융,기중25례(41.0%)환자방전피종지위조2;36례환자경전복률회복SR위조3。평균수방(501±224) d,단차소융성공솔위69.6%(71례)。조1화조2적성공솔(분별위82.9%화76.0%)현저고우조3(50.0%,P치균<0.01)。결론소제량이포리특보조적지속성방전도관소융술료효가이접수,병재실시평고방전유지기질급감소무효CFAE소융등방면구유잠재우세。
Objective To report the efficacy of low-dose ibutilide facilitated catheter ablation for per-sistent atrial fibrillation(PsAF). Methods One hundred and two consecutive patients [68 men,34 women, mean age of(62±11)years] who underwent index catheter ablation for PsAF were enrolled from November 2011 to April 2013 in this prospective study. After circumferential pulmonary vein isolation ( CPVI ) , low-dose (0. 25 mg) ibutilide was administered over 3 min in patients without PsAF termination. In case of PsAF was terminated,either converted to sinus rhythm( SR) or transformed to atrial tachycardia( AT) by ibutilide within 30 minutes,no further ablation targeting complex fractionated atrial electrogram( CFAE) was performed. In con-trast, CFAE ablation was performed until SR restored or all CFAE was eliminated or CFAE ablation time achieved 30 minutes. Results In 41(40. 2%) patients,PsAF was terminated by CPVI±ibutilide(Group 1). Further CFAE ablation was performed in another 61(59. 8%) patients,in whom PsAF was terminated by CFAE ablation in 25 patients(Group 2) or by external cardioversion in 36 patients(Group 3). The mean CFAE abla-tion time was(14. 0±5. 6) min. After a mean follow-up of(501±224) d,the success rate after the index ablation procedure was 69. 6%(71 patients). The success rate of Group 1 and Group 2 was 82. 9% and 76. 0%,respec-tively. Both were significantly higher than that in Group 3(50%,P<0. 01 for both). Conclusion The efficacy of low-dose ibutilide facilitated catheter ablation for PsAF is acceptable,with potential strengths in on-line eval-uating the atrial maintenance substrate and reducing ineffective CFAE ablation.